PTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 2,812 Shares
MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) VP Mark Elliott Boulding sold 2,812 shares of the firm's stock in a transaction on Friday, May 15th. The shares were sold at an average price of $72.18, for a total value of $202,970.16. Following the completion of the transaction, the vice president owned 105,212 shares in the company, valued at $7,594,202.16. The trade was a 2.60% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:PTCT